Similar Items: Investigation of genetic variation contributing to antipsychotic treatment response in a South African first episode schizophrenia cohort
- Molecular genetic analyses of antipsychotic pharmacogenes in a South African first episode schizophrenia cohort
- Investigating the role of miRNA-mediated regulation in antipsychotic treatment response in a South African first-episode schizophrenia cohort
- Molecular genetic analyses of antipsychotic pharmacogenes in a South African first episode schizophrenia cohort
- Investigating the functional significance of genome-wide variants associated with antipsychotic treatment response in schizophrenia
- Combining depot antipsychotic with an assertive monitoring programme for treating first-episode schizophrenia in a resource- constrained setting
- The confirmatory factor structure of neurological soft signs in Nigerians with first episode schizophrenia
Author: Warnich, L.
- The molecular characterisation of the annexin II gene in pre-eclampsia
- Effect of genetic variants in genes encoding two nuclear receptors (PXR and CAR) on efavirenz levels and treatment outcome in South African HIV-infected females
- Sequence-tagged sites of cDNA clones in Solanum tuberosum and their evaluation as molecular markers in Solanaceae species
- Molecular analysis of GJB2 (connexin 26) and GJB6 (connexin 30) gene mutations in non-syndromic hereditary deafness in South Africa
- Molecular genetic analyses of antipsychotic pharmacogenes in a South African first episode schizophrenia cohort
- Investigating the functional significance of genome-wide variants associated with antipsychotic treatment response in schizophrenia